Search Results - "GRANT, Susan L"

An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells by GRANT, Susan L, HAMMACHER, Annet, DOUGLAS, Andrea M, GOSS, Geraldine A, MANSFIELD, Rachel K, HEATH, John K, BEGLEY, C. Glenn

“…Oncostatin M (OSM), an interleukin-6 type cytokine, acts via the gp130 signaling receptor to inhibit proliferation and induce differentiation of breast cancer…”
Get full text

Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes by WEISS, Thomas W, SPEIDL, Walter S, FUERNKRANZ, Alexander, BIALY, Jan, ULLRICH, Robert, HOLZMANN, Philipp, PACHER, Richard, MAURER, Gerald, HUBER, Kurt, WOJTA, Johann, KAUN, Christoph, REGA, Gersina, SPRINGER, Christopher, MACFELDA, Karin, LOSERT, Udo M, GRANT, Susan L, MARRO, Martin L, RHODES, Andrew D

“…In murine and rat cardiac myocytes the gp130 system transduces survival as well as hypertrophic signals and via induction of the expression of the potent…”
Get full text

Oncostatin M induces the differentiation of breast cancer cells by Douglas, Andrea M., Grant, Susan L., Gross, Geraldine A., Clouston, David R., Sutherland, Robert L., Begley, C. Glenn

“…We have recently described the action of Oncostatin M (OSM) to inhibit the proliferation of breast cancer cells. In this study we examined the action of OSM on…”
Get full text

Oncostatin M and Leukemia Inhibitory Factor Regulate the Growth of Normal Human Breast Epithelial Cells by Grant, Susan L., Douglas, Andrea M., Goss, Geraldine A., Begley, C. Glenn

“…We have previously reported the inhibitory effects of oncostatin M (OSM) and leukemia inhibitory factor (LIF) on the proliferation of breast cancer cell lines…”
Get full text

The experimental neuroprotectant leukaemia inhibitory factor (LIF) does not compromise antitumour activity of paclitaxel, cisplatin and carboplatin by BOYLE, Frances M, BEATSON, Cecilie, MONK, Robyn, GRANT, Susan L, KUREK, John B

“…Peripheral neuropathy caused by the anticancer agents cisplatin and paclitaxel is a significant dose-limiting toxicity of these drugs. The growth factor…”
Get full text

The oncostatin M signalling pathway: reversing the neoplastic phenotype? by Grant, Susan L., Begley, C.Glenn

“…Oncostatin M (OSM) is a member of the interleukin 6 (IL-6) family of cytokines and was originally identified by its ability to inhibit proliferation of…”
Get full text